Glioblastoma Multiforme
Showing 51 - 75 of 372
Glioblastoma Multiforme Trial in Shijia Zhuang (TMZ)
Recruiting
- Glioblastoma Multiforme
-
Shijia Zhuang, Hebei, Chinathe Second Hospital of HeBei Medical University
Oct 18, 2022
During MR-guided Radiation Therapy for Glioblastoma
Recruiting
- Glioblastoma Multiforme
- Low field (0.35 T) MR-images of the brain at a MRIdian® linac system
-
Zürich, Zurich, SwitzerlandUniversity Hospital Zurich
Sep 29, 2022
Cervical Cancer, Colorectal Cancer, Esophageal Cancer Trial (89Zr-DFO-girentuximab)
Not yet recruiting
- Cervical Cancer
- +13 more
- (no location specified)
Sep 28, 2022
High-grade Glioma, Oligodendroglioma, Astrocytoma Trial (Low-dose OKN-007, BID, Low-dose OKN-007, TID, Mid-dose OKN-007, TID)
Not yet recruiting
- High-grade Glioma
- +3 more
- Low-dose OKN-007, BID
- +3 more
- (no location specified)
Sep 26, 2022
Glioblastoma Multiforme Trial in Los Angeles, Cleveland (Perillyl alcohol)
Recruiting
- Glioblastoma Multiforme
- Perillyl alcohol
-
Los Angeles, California
- +1 more
Sep 23, 2022
Glioblastoma, Glioblastoma Multiforme Trial in Saint Louis (device, procedure, genetic)
Recruiting
- Glioblastoma
- Glioblastoma Multiforme
- Sonobiopsy
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Sep 21, 2022
Advanced Solid Tumors, Solid Tumor, Solid Carcinoma Trial (Belzutifan)
Active, not recruiting
- Advanced Solid Tumors
- +15 more
- (no location specified)
Sep 16, 2022
Glioblastoma Multiforme Trial in Montréal (Metformin)
Active, not recruiting
- Glioblastoma Multiforme
-
Montréal, Quebec, CanadaMontreal Neurological Institute - McGill University Health Centr
Aug 31, 2022
Glioblastoma Multiforme Trial in Baltimore (Dichloroacetate (DCA), Genotype)
Recruiting
- Glioblastoma Multiforme
- Dichloroacetate (DCA)
- Genotype
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Aug 26, 2022
Glioblastoma Multiforme, Recurrent Glioblastoma Trial in United States (TheraSphere GBM)
Recruiting
- Glioblastoma Multiforme
- Recurrent Glioblastoma
- TheraSphere GBM
-
San Francisco, California
- +4 more
Aug 15, 2022
Glioblastoma Multiforme, Anaplastic Astrocytoma, Malignant Brain Tumor Trial in Indianapolis (Cabozantinib)
Terminated
- Glioblastoma Multiforme
- +3 more
-
Indianapolis, IndianaRiley Hospital for Children at IU Health
Jul 21, 2022
Glioblastoma Multiforme (GBM) Radiation Therapy
Not yet recruiting
- Glioblastoma Multiforme
-
St Leonards, New South Wales, Australia
- +1 more
Aug 9, 2022
Glioblastoma Multiforme, Brain Tumors, Gastroesophageal Adenocarcinoma Trial in Lyon Cedex (68Ga-FF58)
Recruiting
- Glioblastoma Multiforme
- +3 more
-
Lyon Cedex, FranceNovartis Investigative Site
Aug 9, 2022
Glioblastoma, Glioblastoma Multiforme, Glioblastoma Multiforme of Brain Trial in Hershey (Posaconazole Pill)
Recruiting
- Glioblastoma
- +3 more
- Posaconazole Pill
-
Hershey, PennsylvaniaPenn State Milton S Hershey Medical Center
Aug 5, 2022
Glioblastoma Multiforme Trial in Manchester (Preoperative brain irradiation (single fraction))
Recruiting
- Glioblastoma Multiforme
- Preoperative brain irradiation (single fraction)
-
Manchester, Greater Manchester, United KingdomThe Christie NHS Foundation Trust
Aug 2, 2022
Glioblastoma Multiforme Trial in Saint Louis (drug, procedure, radiation)
Active, not recruiting
- Glioblastoma Multiforme
- Disulfiram
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Jul 22, 2022
Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Miami (biological, drug, procedure)
Completed
- Malignant Glioma
- +3 more
- Dendritic Cell Vaccine
- +3 more
-
Miami, FloridaUniversity of Miami
Jul 19, 2022
Glioblastoma Multiforme Trial in Australia, United States (Nivolumab, Temozolomide)
Active, not recruiting
- Glioblastoma Multiforme
-
Durham, North Carolina
- +19 more
Jul 14, 2022
Glioblastoma, Glioblastoma Multiforme, Glioblastoma Multiforme of Brain Trial in Hershey (Ketoconazole)
Recruiting
- Glioblastoma
- +3 more
-
Hershey, PennsylvaniaPenn State Milton S Hershey Medical Center
Jul 12, 2022